Home›Research›Compare›Ac-SDKP vs Cagrilintide
Peptide Comparison
Ac-SDKP vs Cagrilintide
Ac-SDKP
N-acetyl-seryl-aspartyl-lysyl-proline
No providers listed yet
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
Quick Verdict
Ac-SDKP
Risk
Half-life
—
Cagrilintide
Risk
Half-life
~7 days
Side-by-Side Comparison
About Ac-SDKP
Inhibits hematopoietic stem cell entry into S-phase. Blocks TGF-β1-mediated fibroblast activation, reducing collagen deposition. Promotes angiogenesis via VEGF upregulation. Regulated in vivo by ACE enzyme.
A naturally occurring tetrapeptide derived from thymosin beta-4 cleavage by prolyl oligopeptidase. Potent anti-fibrotic properties studied in cardiac, pulmonary, and renal fibrosis. Also promotes angiogenesis and wound healing.
Research Areas
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
Find Providers
Where to source these peptides
Providers offering
Ac-SDKP
Browse directory →
Providers offering
Cagrilintide
13 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.